ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.
Saved in:
| Title: | ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis. |
|---|---|
| Authors: | Harrison, Linda J.1 (AUTHOR) lharriso@sdac.harvard.edu, Velásquez, Gustavo E.2,3 (AUTHOR), Kempker, Russell R.4 (AUTHOR), Imperial, Marjorie Z.2,5 (AUTHOR), Nuermberger, Eric6 (AUTHOR), Dorman, Susan E.7 (AUTHOR), Ignatius, Elisa6 (AUTHOR), Granche, Janeway1 (AUTHOR), Phillips, Patrick P. J.2,8 (AUTHOR), Furin, Jennifer9 (AUTHOR), Yang, Eunsol2,5 (AUTHOR), Foley, Colleen10 (AUTHOR), Chiambah, Shawn11 (AUTHOR), Rogers, Rochelle11 (AUTHOR), Van Grack, Austin12 (AUTHOR), Roa, Jhoanna12 (AUTHOR), Shenje, Justin13 (AUTHOR), Nerette, Sandy14 (AUTHOR), Kanyama, Cecilia15 (AUTHOR), Kyeyune, Rachel Bakyayita16 (AUTHOR) |
| Source: | Trials. 8/15/2025, Vol. 26 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
